U.S. Stem Cell Inc (USRM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:U.S. Stem Cell Inc (USRM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7446
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
U.S. Stem Cell Inc (U.S. Stem Cell), formerly Bioheart, Inc, is a biotechnology company that focuses on the discovery, development and commercialization of cell based therapeutics products. The company repairs and replaces damaged or aged tissue, cells and organs and restoring their normal function. The company’s lead product MyoCell, is designed to populate regions of scar tissue within a patient’s heart with autologous muscle cells, or cells from a patient’s body, to improve cardiac function in chronic heart failure patients. Its services includes the development of proprietary cell therapy products based on regenerative medicine and cell therapy training services, cell collection and cell storage services, sale of cell collection and treatment kits for humans and animals, and operation of a cell therapy clinic. U.S. Stem Cell is headquartered in Sunrise, Florida, the US.

U.S. Stem Cell Inc (USRM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
U.S. Stem Cell Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
U.S. Stem Cell Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
U.S. Stem Cell Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
U.S. Stem Cell Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
U.S. Stem Cell Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
U.S. Stem Cell Inc, Medical Equipment, Deal Details 11
Venture Financing 11
U.S. Stem Cell Raises USD0.3 Million in Venture Financing 11
Private Equity 12
General American Capital to Invest up to USD5 Million in US Stem Cell 12
Partnerships 13
Bioheart Extends Licensing Agreement With Airspeed Equity 13
Bioheart Enters Into Licensing Agreement With Ageless Regenerative Institute For Adipose Cell Technology 14
Equity Offering 15
Bioheart to Raise USD3 Million in Private Placement of Shares 15
Bioheart Completes Private Placement Of Shares For US$3 Million 16
Bioheart Completes Private Placement Of Shares 17
Bioheart Announces Private Placement Of Shares For US$2 Million 18
Debt Offering 19
Bioheart Raises USD3 Million in Private Placement of Notes 19
Acquisition 20
Bioheart to Acquire Pavillion Scientific 20
Bioheart to Invest in Ascyrus Medical 21
U.S. Stem Cell Inc – Key Competitors 22
U.S. Stem Cell Inc – Key Employees 23
U.S. Stem Cell Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 24
Recent Developments 25
Financial Announcements 25
Aug 08, 2018: USRM posts profitable results for second quarter 2018 25
May 09, 2018: U.S. Stem Cell Reports First Quarter Results 26
Apr 16, 2018: USRM Reports 2017 Financial Results 27
Aug 09, 2017: U.S. Stem Cell Reports Most Successful Financial Performance in the Company’s History 28
Corporate Communications 29
Sep 11, 2018: USRM hires senior VP of US & international sales 29
Legal and Regulatory 30
Aug 28, 2017: FDA warns US Stem Cell Clinic of significant deviations 30
Product News 31
May 14, 2018: Autologous Stem Cell Therapy May Hold Key to Regeneration 31
Other Significant Developments 32
Apr 24, 2018: Market Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales 32
Feb 06, 2018: USRM Seeing Explosive Increase in Demand for Stem Cell Therapy 33
Aug 28, 2017: U.S. Stem Cell Clinic Acknowledges Warning Letter By The FDA and Responds 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
U.S. Stem Cell Inc, Medical Equipment, Key Facts, 2017 2
U.S. Stem Cell Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
U.S. Stem Cell Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
U.S. Stem Cell Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
U.S. Stem Cell Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
U.S. Stem Cell Inc, Deals By Market, 2012 to YTD 2018 9
U.S. Stem Cell Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
U.S. Stem Cell Raises USD0.3 Million in Venture Financing 11
General American Capital to Invest up to USD5 Million in US Stem Cell 12
Bioheart Extends Licensing Agreement With Airspeed Equity 13
Bioheart Enters Into Licensing Agreement With Ageless Regenerative Institute For Adipose Cell Technology 14
Bioheart to Raise USD3 Million in Private Placement of Shares 15
Bioheart Completes Private Placement Of Shares For US$3 Million 16
Bioheart Completes Private Placement Of Shares 17
Bioheart Announces Private Placement Of Shares For US$2 Million 18
Bioheart Raises USD3 Million in Private Placement of Notes 19
Bioheart to Acquire Pavillion Scientific 20
Bioheart to Invest in Ascyrus Medical 21
U.S. Stem Cell Inc, Key Competitors 22
U.S. Stem Cell Inc, Key Employees 23
U.S. Stem Cell Inc, Joint Venture 24

List of Figures
U.S. Stem Cell Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
U.S. Stem Cell Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
U.S. Stem Cell Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
U.S. Stem Cell Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
U.S. Stem Cell Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
U.S. Stem Cell Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
U.S. Stem Cell Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
U.S. Stem Cell Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[U.S. Stem Cell Inc (USRM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Piraeus Bank SA:企業のM&A・事業提携・投資動向
    Piraeus Bank SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Piraeus Bank SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Pioneer Corporation:企業の戦略・SWOT・財務分析
    Pioneer Corporation - Strategy, SWOT and Corporate Finance Report Summary Pioneer Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Central Alabama Electric Cooperative Inc:企業の戦略的SWOT分析
    Central Alabama Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • SRT Marine Systems plc (SRT):企業の財務・戦略的SWOT分析
    SRT Marine Systems plc (SRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Advantest Corporation (6857):企業の財務・戦略的SWOT分析
    Advantest Corporation (6857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Busan Bank Co., Ltd.:企業の戦略・SWOT・財務情報
    Busan Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Busan Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Saudi Telecom Company:企業の戦略・SWOT・財務分析
    Saudi Telecom Company - Strategy, SWOT and Corporate Finance Report Summary Saudi Telecom Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Airbus SE (AIR):企業の財務・戦略的SWOT分析
    Airbus SE (AIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Fluor Corporation:戦略・SWOT・企業財務分析
    Fluor Corporation - Strategy, SWOT and Corporate Finance Report Summary Fluor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • George Weston Limited (WN):企業の財務・戦略的SWOT分析
    George Weston Limited (WN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • ExxonMobil Pipeline Co:石油・ガス:M&Aディール及び事業提携情報
    Summary ExxonMobil Pipeline Co (EMPCO) a subsidiary of Exxon Mobil Corporation is an oil and gas company that offers petroleum products transportation solutions. The company transports crude oil, refined products, liquefied petroleum gases, natural gas liquids and chemical feed-stocks. Its distribut …
  • Tessco Technologies Incorporated (TESS):企業の財務・戦略的SWOT分析
    Tessco Technologies Incorporated (TESS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • EnBW Energie Baden-Wurttemberg AG (EBK):石油・ガス:M&Aディール及び事業提携情報
    Summary EnBW Energie Baden-Wurttemberg AG (EnBW) is an integrated energy company. Through its subsidiaries, the company generates, procures, transmits, and supplies electricity; and produces, transports and supplies gas. It produces electricity in coal, gas, pumped storage, and nuclear power plants. …
  • PJSC Detsky Mir (DSKY):企業の財務・戦略的SWOT分析
    PJSC Detsky Mir (DSKY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Lincoln National Corporation:戦略・SWOT・企業財務分析
    Lincoln National Corporation - Strategy, SWOT and Corporate Finance Report Summary Lincoln National Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Guthy-Renker LLC:企業の戦略的SWOT分析
    Guthy-Renker LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • EnerDel Inc:企業の戦略的SWOT分析
    EnerDel Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Huge China Holdings Limited (428):企業の財務・戦略的SWOT分析
    Huge China Holdings Limited (428) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Lexicon Pharmaceuticals Inc (LXRX):企業の財務・戦略的SWOT分析
    Lexicon Pharmaceuticals Inc (LXRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Dais Analytic Corps (DLYT):企業の財務・戦略的SWOT分析
    Summary Dais Analytic Corps (Dais) is an alternative energy company that provides industry changing and nano technology based applications. The company's products include ultra capacitors, clean water systems, heating and cooling equipment, among others. It also provides NanoAir, NanoCap, ConsERV an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆